These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 23768559)

  • 21. Targeting Dysbiosis for the Treatment of Liver Disease.
    Anand G; Zarrinpar A; Loomba R
    Semin Liver Dis; 2016 Feb; 36(1):37-47. PubMed ID: 26870931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the gut microbiota in nutrition and health.
    Flint HJ; Scott KP; Louis P; Duncan SH
    Nat Rev Gastroenterol Hepatol; 2012 Oct; 9(10):577-89. PubMed ID: 22945443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota and obesity.
    Krznarić Z; Vranešić Bender D; Kunović A; Kekez D; Stimac D
    Dig Dis; 2012; 30(2):196-200. PubMed ID: 22722438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prebiotics and probiotics; modifying and mining the microbiota.
    Quigley EM
    Pharmacol Res; 2010 Mar; 61(3):213-8. PubMed ID: 20080184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prebiotics and Probiotics in Digestive Health.
    Quigley EMM
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):333-344. PubMed ID: 30267869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease.
    Wasilewski A; Zielińska M; Storr M; Fichna J
    Inflamm Bowel Dis; 2015 Jul; 21(7):1674-82. PubMed ID: 25822014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
    Frazier TH; DiBaise JK; McClain CJ
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
    Cho MS; Kim SY; Suk KT; Kim BY
    J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the gut microbiota, prebiotics, and probiotics on human health and disease.
    Lin CS; Chang CJ; Lu CC; Martel J; Ojcius DM; Ko YF; Young JD; Lai HC
    Biomed J; 2014; 37(5):259-68. PubMed ID: 25179725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probiotics and prebiotics and health in ageing populations.
    Duncan SH; Flint HJ
    Maturitas; 2013 May; 75(1):44-50. PubMed ID: 23489554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human intestinal microbiota and healthy ageing.
    Tiihonen K; Ouwehand AC; Rautonen N
    Ageing Res Rev; 2010 Apr; 9(2):107-16. PubMed ID: 19874918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the microbiota in infectious diseases.
    Libertucci J; Young VB
    Nat Microbiol; 2019 Jan; 4(1):35-45. PubMed ID: 30546094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota.
    Cani PD; Delzenne NM
    Curr Opin Pharmacol; 2009 Dec; 9(6):737-43. PubMed ID: 19628432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probiotics and liver disease.
    Sharma V; Garg S; Aggarwal S
    Perm J; 2013; 17(4):62-7. PubMed ID: 24361022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of gut microbiota with functional food components and nutraceuticals.
    Laparra JM; Sanz Y
    Pharmacol Res; 2010 Mar; 61(3):219-25. PubMed ID: 19914380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes, obesity and gut microbiota.
    Everard A; Cani PD
    Best Pract Res Clin Gastroenterol; 2013 Feb; 27(1):73-83. PubMed ID: 23768554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synbiotics as Supplemental Therapy for the Alleviation of Chemotherapy-Associated Symptoms in Patients with Solid Tumours.
    Singh NK; Beckett JM; Kalpurath K; Ishaq M; Ahmad T; Eri RD
    Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prebiotics and synbiotics: dietary strategies for improving gut health.
    Krumbeck JA; Maldonado-Gomez MX; Ramer-Tait AE; Hutkins RW
    Curr Opin Gastroenterol; 2016 Mar; 32(2):110-9. PubMed ID: 26825589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.